Innovative Pharmaceutical Biotech Limited (HKG:0399)

HKG:0399 Ratios and Metrics

Market cap in millions HKD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 13, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	444	345	305	218	365	373
Market Cap Growth	9.87%	13.16%	39.60%	-40.16%	-2.35%	-36.25%
Enterprise Value	2,269	2,320	2,346	2,076	2,232	1,961
Last Close Price	0.20	0.20	0.21	0.15	0.25	0.26
PE Ratio	45.32	3.33	-	4.76	-	-
PS Ratio	75.33	52.27	37.72	19.58	24.00	25.61
PB Ratio	0.94	1.08	2.17	0.55	1.02	0.66
EV/Sales Ratio	-	351.87	290.52	186.30	146.94	134.48
Debt / Equity Ratio	1.90	3.30	8.80	2.50	2.89	1.47
Asset Turnover	0.00	0.01	0.01	0.01	0.01	0.01
Quick Ratio	0.00	0.02	0.01	0.14	0.03	0.59
Current Ratio	0.01	0.03	0.01	0.19	0.04	0.60
Return on Equity (ROE)	1.76%	42.92%	-95.06%	9.66%	-45.80%	-32.65%
Return on Assets (ROA)	-0.65%	-0.61%	-0.94%	-1.09%	-0.96%	-1.35%
Return on Capital (ROIC)	-0.66%	-0.61%	-0.95%	-1.10%	-0.96%	-1.37%
Earnings Yield	2.58%	30.00%	-80.67%	21.00%	-56.21%	-56.54%
FCF Yield	-	-2.40%	-5.79%	-5.65%	-6.86%	-9.70%
Buyback Yield / Dilution	-107.89%	-70.64%	16.34%	-19.53%	-	-

Updated Dec 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.